BioSpace News Archive

BioMidwest

Modernizing Medicine to Launch Telemedicine Solution to Provide Real-Time Audio and Video Capabilities to Help Healthcare Professionals Care for Patients

modmed® Telehealth; to be available at no additional charge to EMA® customers during COVID-19 crisis

March 16, 2020
·
3 min read
BioMidwest

Blue Cross and Blue Shield of Minnesota Expands COVID-19 Coverage to Include Office Visits and Virtual Care at No Cost

Blue Cross and Blue Shield of Minnesota (Blue Cross), the state’s leading health insurer, has announced immediate no-cost coverage updates as part of its ongoing effort to help prevent the spread and impact of the coronavirus (COVID-19).

March 16, 2020
·
2 min read
Business

CureVac announces leadership update

CureVac AG announced today that Ingmar Hoerr, CEO of the company, will take a temporary leave of absence for medical reasons. Ingmar Hoerr’s leave is not caused by coronavirus

March 16, 2020
·
1 min read
Business

LogicBio Reports Full Year 2019 Financial Results and Provides Business Updates

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, reported financial results and provided a corporate update for the year ended December 31, 2019.

March 16, 2020
·
7 min read
Business

AVEO Oncology Reports Full Year 2019 Financial Results and Provides Business Update

AVEO Oncology reported financial results for the full year ended December 31, 2019 and provided a business update.

March 16, 2020
·
17 min read
Business

Entera Bio To Report 2019 Business And Financial Results On March 26, 2020

Entera Bio Ltd., a leader in the development of orally delivered large molecule therapeutics, announced it will report financial and business results for the quarter and year ended December 31, 2019, on March 26, 2020, before the U.S. financial markets open..

March 16, 2020
·
1 min read
Pharm Country

Seelos Therapeutics Announces Closing of Public Offering of Common Stock

Seelos Therapeutics, Inc. ( announced today the closing of its previously announced underwritten public offering of 7,500,000 shares of its common stock, at a price to the public of $0.60 per share. The net proceeds to Seelos from this offering are expected to be approximately $3.9 million, after de

March 16, 2020
·
3 min read
Business

Mustang Bio Reports Full-Year 2019 Financial Results and Recent Corporate Highlights

Mustang Bio, Inc. today announced financial results and recent corporate highlights for the full year ended December 31, 2019. Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “We are

March 16, 2020
·
13 min read
Business

Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights

Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company, today announced financial results

March 16, 2020
·
25 min read
BioMidwest

Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization

Broad network of labs will use automated cobas SARS-CoV-2 Test to process high volume of patient samples sent from across US

March 16, 2020
·
4 min read